Response to ibudilast treatment according to progressive multiple sclerosis disease phenotype

por Goodman, Andrew D., Fedler, Janel K., Yankey, Jon, Klingner, Elizabeth A., Ecklund, Dixie J., Goebel, Christopher V., Bermel, Robert A., Chase, Marianne, Coffey, Christopher S., Klawiter, Eric C., Naismith, Robert T., Fox, Robert J.
Publicado 2021

Prevalence of Headache Days and Disability 3 Years After Participation in the Childhood and Adolescent Migraine Prevention Medication Trial

por Powers, Scott W., Coffey, Christopher S., Chamberlin, Leigh A., Ecklund, Dixie J., Klingner, Elizabeth A., Yankey, Jon W., Peugh, James L., Korbee, Leslie L., Simmons, Kerry, Sullivan, Stephanie M., Kabbouche, Marielle A., Kacperski, Joanne, Porter, Linda L., Reidy, Brooke L., Hershey, Andrew D.
Publicado 2021

Efficacy of Nilotinib in Patients With Moderately Advanced Parkinson Disease: A Randomized Clinical Trial

por Simuni, Tanya, Fiske, Brian, Merchant, Kalpana, Coffey, Christopher S., Klingner, Elizabeth, Caspell-Garcia, Chelsea, Lafontant, David-Erick, Matthews, Helen, Wyse, Richard K., Brundin, Patrik, Simon, David K., Schwarzschild, Michael, Weiner, David, Adams, Jamie, Venuto, Charles, Dawson, Ted M., Baker, Liana, Kostrzebski, Melissa, Ward, Tina, Rafaloff, Gary
Publicado 2020